Eli Lilly's Ixekizumab Shows Promise As Treatment For Patients With Plaque Psoriasis In three trials of Eli Lilly's Ixekizumab, the drug shows effectiveness in clearing plaque psoriasis. This autoimmune skin disease is hard to treat and can alter one's work productivity. by Angela Laguipo
Healthy Living/Wellness Ixekizumab Is Hard To Read But It Spells Hope For Psoriasis Patients by Rina Marie Doctor